Table S3. Positivity of subjects with NED stratified by plasma volume and age. * Two-sided Fisher’s exact test, p < 0.05 considered statistically significant Fraction: Positive fraction detected. NR: Not Relevant. NED: No Evidence of Disease. (DOC 35 kb
Figure S2. OPLS-DA analysis using 136 glycopeptides extracted by t-test. (a) A score plot for 80 CRC...
The selection process of study sample to determine optimal cut-points for prediction of type 2 diabe...
Table S2. Evaluation of bias in the retrospective cohort studies, as assessed using the Newcastle-Ot...
Table S2. Individuals with CRC stratified by tumorstage and age. p-value <0.001 Fishers exact test. ...
Table S7. Predictors of Colorectal Cancer, 2/3 algorithm. * p < 0.05 considered statistically signif...
Table S8. Sensitivity and specificity for Sept9 after age adjusted combinations of positivity algori...
Table S1. Association between variables in cohort. *Two-sided Fisher’s exact test, all numbers are p...
Table S4. Predictors of CRC in univariate regression, 1/3 algorithm. ¤ p-values for Sept9 2/3 algori...
Table S6. Effect modificators of Sept9 positivity in CRC. ¤ p-values for Sept9 2/3 algorithm similar...
Figure S2. Diabetes and vascular disease plots. The healthy aging signature activation was studied i...
Table S3. Number of screen-detected cases, expected number of detected non-progressive in situ combi...
Selected chronic disease groups and the included diseases in each group together with their ICD-10 c...
Table S3. Detailed measurement of cell viability in therapeutic screening against HCT116 and HT29 ce...
Funnel plots of studies included in the analysis on all-cause death, cardiovascular death, non-fatal...
Time (days) between a first or subsequent screening examination by the Dutch breast cancer screening...
Figure S2. OPLS-DA analysis using 136 glycopeptides extracted by t-test. (a) A score plot for 80 CRC...
The selection process of study sample to determine optimal cut-points for prediction of type 2 diabe...
Table S2. Evaluation of bias in the retrospective cohort studies, as assessed using the Newcastle-Ot...
Table S2. Individuals with CRC stratified by tumorstage and age. p-value <0.001 Fishers exact test. ...
Table S7. Predictors of Colorectal Cancer, 2/3 algorithm. * p < 0.05 considered statistically signif...
Table S8. Sensitivity and specificity for Sept9 after age adjusted combinations of positivity algori...
Table S1. Association between variables in cohort. *Two-sided Fisher’s exact test, all numbers are p...
Table S4. Predictors of CRC in univariate regression, 1/3 algorithm. ¤ p-values for Sept9 2/3 algori...
Table S6. Effect modificators of Sept9 positivity in CRC. ¤ p-values for Sept9 2/3 algorithm similar...
Figure S2. Diabetes and vascular disease plots. The healthy aging signature activation was studied i...
Table S3. Number of screen-detected cases, expected number of detected non-progressive in situ combi...
Selected chronic disease groups and the included diseases in each group together with their ICD-10 c...
Table S3. Detailed measurement of cell viability in therapeutic screening against HCT116 and HT29 ce...
Funnel plots of studies included in the analysis on all-cause death, cardiovascular death, non-fatal...
Time (days) between a first or subsequent screening examination by the Dutch breast cancer screening...
Figure S2. OPLS-DA analysis using 136 glycopeptides extracted by t-test. (a) A score plot for 80 CRC...
The selection process of study sample to determine optimal cut-points for prediction of type 2 diabe...
Table S2. Evaluation of bias in the retrospective cohort studies, as assessed using the Newcastle-Ot...